Pfizer Inc.
Pfizer Inc. PFE.F Peers
See (PFE.F) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PFE.F | $20.84 | +4.33% | 118.48B | 17.08 | $1.22 | +7.02% |
| LLY.DE | $675.90 | +1.05% | 640.57B | 62.58 | $10.80 | +0.70% |
| JNJ.DE | $139.56 | +1.01% | 336.32B | 17.60 | $7.93 | +3.11% |
| 4AB.DE | $172.60 | +3.48% | 305.33B | 83.38 | $2.07 | +3.17% |
| ZEG.DE | $122.50 | +1.16% | 189.95B | 27.97 | $4.38 | +2.23% |
| 6MK.DE | $71.50 | +3.62% | 179.54B | 11.78 | $6.07 | +3.82% |
| AMG.DE | $246.25 | +2.65% | 132.41B | 25.47 | $9.67 | +3.47% |
| PFE.DE | $20.67 | +3.47% | 117.52B | 16.94 | $1.22 | +7.07% |
| GIS.DE | $92.59 | +7.50% | 115.18B | 22.05 | $4.20 | +2.93% |
| SNW.DE | $91.12 | -1.74% | 110.99B | 18.26 | $4.99 | +8.43% |
Stock Comparison
PFE.F vs LLY.DE Comparison
PFE.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFE.F stands at 118.48B. In comparison, LLY.DE has a market cap of 640.57B. Regarding current trading prices, PFE.F is priced at $20.84, while LLY.DE trades at $675.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFE.F currently has a P/E ratio of 17.08, whereas LLY.DE's P/E ratio is 62.58. In terms of profitability, PFE.F's ROE is +0.09%, compared to LLY.DE's ROE of +0.77%. Regarding short-term risk, PFE.F is less volatile compared to LLY.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PFE.F.